Navigation Links
The 'Anatomy' of Clinical Trials: 'Grey's' Season Finale Leaves Public in the Dark About the Myths and Realities
Date:5/22/2008

Coalition of Cancer Cooperative Groups sheds light on the fact that cancer clinical trials like those on Grey's Anatomy are not just 'do or die.'

PHILADELPHIA, May 22 /PRNewswire/ -- With the past several episodes and two-hour season finale of "Grey's Anatomy" centered on the emotional sagas of cancer clinical trial patients and their doctors, the subject tops the list of the country's healthcare "hot topics." While "Grey's" has done a service in making the public aware that cancer clinical trial options exist, the concern is that the drama which makes for a compelling prime-time show doesn't allow for an accurate, nor complete, portrayal of the role clinical trials play in guaranteeing continued progress in the fight against cancer.

The season finale this Thursday will only contribute to the negative perception being portrayed on the show that cancer "clinical trials" usually equal a "death sentence."

"Cancer clinical trials are highly-structured and follow a well-defined protocol with careful supervision," said Robert L. Comis, MD, President and Chairman of the Coalition of Cancer Cooperative Groups. "Trials can provide patients at all stages of cancer with the most cutting-edge medical treatment, the highest level of care and the possibility of more effective therapy than if they went the standard course. A clinical trial is a treatment option to be considered at the point of diagnosis-not only a last-ditch effort when all other options are exhausted."

A clinical trial is a carefully monitored medical research study in which people participate to test new methods of prevention, screening, diagnosis, or treatment of a disease. The majority of patients who participate in cancer clinical trials do so in phase III studies, which are designed to evaluate whether a new treatment or procedure is more effective than the current standard of care.

The knowledge gained through cancer clinical trial research has helped scientists and doctors develop new ways to slow, halt, cure and prevent cancer. However, of the 1.3 million people who will be diagnosed with cancer this year, only 3 to 5 percent of adults will participate in cancer clinical trials.

The Coalition of Cancer Cooperative Groups is a nonprofit organization with a goal to improve the quality of life and survival of cancer patients by increasing participation in cancer clinical trials as treatment options-not last-hope efforts. As a non-profit, the Coalition offers the added benefit of providing non-biased cancer clinical trial information.

At the core of the Coalition's service is their online TrialCheck(R), the nation's premier free cancer clinical trials navigation and matching service offering the most up-to-date source of cancer clinical trial information. Used by organizations such as American Cancer Society, American Society of Clinical Oncology, the state of Georgia, and soon The Leukemia & Lymphoma Society, the award-winning TrialCheck is accessible to more than 3 million patients and caregivers each month.

"Clinical research has led to almost all cancer treatments used today," said Comis. "Because of the knowledge gained through clinical trials, approximately two-thirds of cancer patients survive at least five years after diagnosis, compared with only fifty percent in the 1970s. We need to keep reinforcing this fact and encouraging patients and their physicians to look at all the options when facing a cancer diagnosis."

Advances identified through clinical trials include: Cancer screening techniques, such as mammograms; adjuvant chemotherapy (chemo after surgery); therapies targeting genetic and molecular defects that make a cell cancerous; Cancer vaccines and "chemoprevention" drugs; profiling of cancer genes; and new insights into the long-term health of cancer survivors, who are at greater risk of heart problems, second cancers and other health issues.

Certainly, misperceptions about the negativity of clinical trials for treating cancer patients existed before Grey's, but the episodes have heightened the dynamic, making now the crucial time to set the record straight ... to debunk the myths and reinforce the fact that only patient participation in clinical trials will guarantee continued progress in the fight against cancer.

"Cancer clinical trial patients do not need to fear the possibility of not receiving treatment ... placebos are never given in place of treatment when an existing standard therapy exists," said Comis. "Our goal right now is to provide the public with the knowledge that helps them distinguish entertainment fiction from the reality of cancer clinical trial benefits."

About the Coalition of Cancer Cooperative Groups

The Coalition of Cancer Cooperative Groups is the nation's only nonprofit organization of its kind, devoted solely to the improvement of patient access to cancer clinical trials. Comprised of members from the 10 National Cancer Institute-sponsored Cooperative Groups, dozens of patient advocacy organizations and 8,000 oncology and cancer research specialists, the Coalition is helping to increase awareness of cancer clinical trials as a treatment option through information and services at http://www.CancerTrialsHelp.org .


'/>"/>
SOURCE The Coalition of Cancer Cooperative Groups
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
2. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
3. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
4. ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
5. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
6. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
7. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
8. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
9. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
10. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
11. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Calif. , Feb. 9, 2016  Increasingly, health ... monitoring their vital signs with wireless technology. With the ... can automate patient oversight and remotely detect problems before ... vital signs across in-hospital environments. the ... the United States . --> ...
(Date:2/9/2016)... HONG KONG , Feb. 9, 2016 ... has joined Athenex as Vice President of Corporate Strategy and ... Yeung , MSc, MBA has joined as Senior Director and Deputy ... Hong Kong . Simon Pedder stated, ... have known for a while. Coupled together with their unique ...
(Date:2/8/2016)... -- Cardiac Assist Devices - Medical ... Medical Devices sector report, " Cardiac Assist Devices ... an overview of Cardiac Assist Devices currently in ... on the pipeline products with comparative analysis of ... report reviews major players involved in the pipeline ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... 09, 2016 , ... Two renowned photographers, Robert Caplin (New York, NY) and ... island, June 14-19, 2016, hosted by Four Seasons Resort Maui at Wailea as part ... debut in 2015, the Maui Photo Expedition workshop will once again consist ...
(Date:2/9/2016)... VA (PRWEB) , ... February 09, 2016 , ... ... Small Mammal Prize has officially been won. A team from 21st Century Medicine ... discovered a way to preserve the delicate neural circuits of an intact rabbit ...
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance ... beginning of a new charity campaign. As part of their ongoing community involvement ... In the belief that children deserve a voice, and in the spirit of ...
(Date:2/8/2016)... N.J. (PRWEB) , ... February 08, 2016 , ... ... protective footwear and clothing, announced expansion into Canada to provide its range of ... opened a sales office in Quebec City that will provide bilingual customer service ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... relationship-marketing firm, announced today that nominations will be accepted February 8, 2016 ... Awards. , Awards include the Information Security Executive® of the Year, ...
Breaking Medicine News(10 mins):